Različica SARS-CoV-2 omikron (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Različica SARS-CoV-2 omikron" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

5doi.org

2^nd place

5^th place

4web.archive.org

1^st place

2^nd place

3nih.gov

4^th place

8^th place

2medrxiv.org

low place

2semanticscholar.org

11^th place

51^st place

1nijz.si

low place

229^th place

1who.int

195^th place

64^th place

1worldcat.org

5^th place

10^th place

1harvard.edu

18^th place

31^st place

1nytimes.com

7^th place

37^th place

1umn.edu

1,266^th place

1,210^th place

1healthline.com

3,733^rd place

1,103^rd place

doi.org

Gowrisankar A, Priyanka TM, Banerjee S (10. januar 2022). »Omicron: a mysterious variant of concern«. The European Physical Journal Plus (v angleščini). 137 (1): 100. doi:10.1140/epjp/s13360-021-02321-y. ISSN 2190-5444. PMC 8743750.
Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M (Julij 2022). »Advances in the Omicron variant development«. Journal of Internal Medicine. 292 (1): 81–90. doi:10.1111/joim.13478. PMC 9115048. PMID 35289434.
Lewnard, Joseph A.; Hong, Vennis X.; Patel, Manish M.; Kahn, Rebecca; Lipsitch, Marc; Tartof, Sara Y. (11. januar 2022). »Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California« (v angleščini): 2022.01.11.22269045. doi:10.1101/2022.01.11.22269045. S2CID 245851556. {{navedi časopis}}: Sklic journal potrebuje|journal= (pomoč)
Ahmed SF, Quadeer AA, McKay MR (Januar 2022). »SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron«. Viruses. 14 (1): 79. doi:10.3390/v14010079.
Al Jurdi A, Gassen RB, Borges TD, Lape IT, Morena L, Efe O, in sod. (6. januar 2022). »Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients« (v angleščini): 2022.01.03.22268649. doi:10.1101/2022.01.03.22268649. S2CID 245739956. {{navedi časopis}}: Sklic journal potrebuje|journal= (pomoč)

harvard.edu

health.harvard.edu

Harvard Medical School (6. januar 2022). »Coronavirus Resource Center - Harvard Health«. Harvard Health Publishing. Arhivirano iz prvotnega spletišča dne 11. januarja 2022. Pridobljeno 7. januarja 2022. Lab studies, animal studies, and epidemiological data all indicate that Omicron may cause less severe disease than previous variants.

healthline.com

»How Effective Are COVID-19 Vaccines Against Omicron?«. Healthline (v angleščini). 7. januar 2022. Pridobljeno 17. januarja 2022.

medrxiv.org

Lewnard, Joseph A.; Hong, Vennis X.; Patel, Manish M.; Kahn, Rebecca; Lipsitch, Marc; Tartof, Sara Y. (11. januar 2022). »Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California« (v angleščini): 2022.01.11.22269045. doi:10.1101/2022.01.11.22269045. S2CID 245851556. {{navedi časopis}}: Sklic journal potrebuje|journal= (pomoč)
Al Jurdi A, Gassen RB, Borges TD, Lape IT, Morena L, Efe O, in sod. (6. januar 2022). »Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients« (v angleščini): 2022.01.03.22268649. doi:10.1101/2022.01.03.22268649. S2CID 245739956. {{navedi časopis}}: Sklic journal potrebuje|journal= (pomoč)

nih.gov

ncbi.nlm.nih.gov

Gowrisankar A, Priyanka TM, Banerjee S (10. januar 2022). »Omicron: a mysterious variant of concern«. The European Physical Journal Plus (v angleščini). 137 (1): 100. doi:10.1140/epjp/s13360-021-02321-y. ISSN 2190-5444. PMC 8743750.
Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M (Julij 2022). »Advances in the Omicron variant development«. Journal of Internal Medicine. 292 (1): 81–90. doi:10.1111/joim.13478. PMC 9115048. PMID 35289434.

pubmed.ncbi.nlm.nih.gov

Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M (Julij 2022). »Advances in the Omicron variant development«. Journal of Internal Medicine. 292 (1): 81–90. doi:10.1111/joim.13478. PMC 9115048. PMID 35289434.

nijz.si

»Omejitev širjenja različice omikron«. Nijz.si. 2. december 2021. Arhivirano iz prvotnega spletišča dne 21. januarja 2022. Pridobljeno 21. januarja 2022.

nytimes.com

David Leonhardt (5. januar 2022). »Omicron Is Milder«. The New York Times. Pridobljeno 7. januarja 2022. A few weeks ago, many experts and journalists were warning that the initial evidence from South Africa — suggesting that Omicron was milder than other variants — might turn out to be a mirage. It has turned out to be real.

semanticscholar.org

api.semanticscholar.org

Lewnard, Joseph A.; Hong, Vennis X.; Patel, Manish M.; Kahn, Rebecca; Lipsitch, Marc; Tartof, Sara Y. (11. januar 2022). »Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California« (v angleščini): 2022.01.11.22269045. doi:10.1101/2022.01.11.22269045. S2CID 245851556. {{navedi časopis}}: Sklic journal potrebuje|journal= (pomoč)
Al Jurdi A, Gassen RB, Borges TD, Lape IT, Morena L, Efe O, in sod. (6. januar 2022). »Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients« (v angleščini): 2022.01.03.22268649. doi:10.1101/2022.01.03.22268649. S2CID 245739956. {{navedi časopis}}: Sklic journal potrebuje|journal= (pomoč)

umn.edu

cidrap.umn.edu

»Lung tissue study sheds light on fast Omicron spread«. CIDRAP. Arhivirano iz spletišča dne 16. decembra 2021. Pridobljeno 25. decembra 2021.

web.archive.org

»Omejitev širjenja različice omikron«. Nijz.si. 2. december 2021. Arhivirano iz prvotnega spletišča dne 21. januarja 2022. Pridobljeno 21. januarja 2022.
»Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern«. World Health Organization. 26. november 2021. Arhivirano iz spletišča dne 26. novembra 2021. Pridobljeno 26. novembra 2021.
Harvard Medical School (6. januar 2022). »Coronavirus Resource Center - Harvard Health«. Harvard Health Publishing. Arhivirano iz prvotnega spletišča dne 11. januarja 2022. Pridobljeno 7. januarja 2022. Lab studies, animal studies, and epidemiological data all indicate that Omicron may cause less severe disease than previous variants.
»Lung tissue study sheds light on fast Omicron spread«. CIDRAP. Arhivirano iz spletišča dne 16. decembra 2021. Pridobljeno 25. decembra 2021.

who.int

»Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern«. World Health Organization. 26. november 2021. Arhivirano iz spletišča dne 26. novembra 2021. Pridobljeno 26. novembra 2021.

worldcat.org

Gowrisankar A, Priyanka TM, Banerjee S (10. januar 2022). »Omicron: a mysterious variant of concern«. The European Physical Journal Plus (v angleščini). 137 (1): 100. doi:10.1140/epjp/s13360-021-02321-y. ISSN 2190-5444. PMC 8743750.